DDX5011P-100 Mabthera (Rituximab) antibody

See related secondary antibodies

Search for all "Mabthera (Rituximab)"

0.1 mg / €230.00
Please visit the country specific website of OriGene Technologies or contact your local Distributor to buy this product.

Quick Overview

Mouse anti Human Mabthera (Rituximab) 108F11.02


More Views

  • DDX5011P-100
  • DDX5011P-100

Product Description for Mabthera (Rituximab)

Mouse anti Human Mabthera (Rituximab) 108F11.02.
Presentation: Purified

Properties for Mabthera (Rituximab)

Product Category Primary Antibodies
Quantity 0.1 mg
Presentation Purified
Reactivity Hu
Clonality Monoclonal
Clone 108F11.02
Host Mouse
Isotype IgG1
Shipping to Germany, USA/Canada
PDF datasheet View Datasheet
Manufacturer Dendritics SAS

Datasheet Extract

Mabthera® (Roche) (Rituximab)
Isotype control AM03095PU-N, SM10P (for use in human samples)
Application DDX5010P-50 / DDX5010P-100 Purified: Bridging Elisa positive control for anti-Mabthera detection,
Capture antibody for anti-Mabthera detection.
DDX5010B-50 DDX5010B-100 Biotin: Detection antibody for Mabthera detection. 

DDX5011P-50 / DDX5011P-100 Purified: Bridging Elisa positive control for anti-Mabthera detection.
DDX5011B-50 DDX5011B-100 Biotin: Detection antibody for Mabthera detection. 

Usage recommendation:
*This monoclonal antibody may be used between 5-25μg/ml.
*Optimal dilution should be determined by each laboratory for each application.
*Coupled antibody: to maintain RT before use.
Background Mabthera ® (Rituximab) is a chimeric monoclonal antibody targeting the CD20 protein expressed on B cell surface. Mabthera ® (Rituximab ) destroys B cells and is therefore used to treat diseases such as lymphomas, leukemias, transplant rejection, and autoimmune disorders. Mabthera® (Rituximab) has also been shown to be an effect ive rheumatoid arthritis treatment, in cases where anti - TNF - alpha therapy is not satisfactory. We have generated a panel of anti - Mabthera® (anti - Rituximab) monoclonal murine antibodies. These antibodies can be used to develop and calibrate Mabthera (Rituximab) and anti - Mabthera (anti - Rituximab) detection assays.
Concentration 0.5 mg/ml
Storage -20°C. KEEP CONTENTS STERILE: no preservative.
Purified antibodies: avoid repeated freeze/thaw cycles.
Coupled antibodies: glycerol protects from freezing.
QMA Hyper D ion exchange chromatography
Buffer System:
Purified: 100 μg in 200 μl / 50 μg in 100 μl Tris-NaCl pH 8.
Coupled: 100 μg in 200 μl / 50 μg in 100 μl PBS 50% glycerol.
Mabthera ® (Rituximab), negative for remicade (infliximab) and roactemra (tocilizumab). 
Cross-reactivity: Negative for remicade (infliximab) and roactemra (tocilizumab).

Accessory Products

  • LinkedIn